TipRanks
Immunovant (DE:4YB)
STUTTGART:4YB

Compare Immunovant (4YB) vs. Competitors

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Immunovant
―
€5.43B
-10.18
7 Buy
3 Hold
0 Sell
Moderate Buy
TG Therapeutics
$55.42
$8.46B
17.85
58.80%
4 Buy
0 Hold
1 Sell
Moderate Buy
Viridian Therapeutics
$24.18
$2.07B
-5.16
-14.74%
12 Buy
0 Hold
0 Sell
Strong Buy
Aurinia Pharmaceuticals
$16.75
$2.20B
6.93
47.39%
2 Buy
1 Hold
0 Sell
Moderate Buy
Protagonist Therapeutics
$150.59
$9.37B
113.69
74.93%
14 Buy
0 Hold
0 Sell
Strong Buy
Kymera Therapeutics
$125.55
$9.32B
-32.82
78.13%
14 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:4YB
Immunovant
―
―
―
TGTX
TG Therapeutics
54.34
19.29
55.04%
VRDN
Viridian Therapeutics
18.22
-4.05
-18.19%
AUPH
Aurinia Pharmaceuticals
16.36
4.89
42.63%
PTGX
Protagonist Therapeutics
138.49
60.81
78.28%
KYMR
Kymera Therapeutics
106.68
43.79
69.63%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts